SCHEDULE 13G: JPMorgan Chase & Co. Discloses 6.4% Passive Stake in Oscar Health, Inc.

JPMorgan Chase & Co. has reported a 6.4% beneficial ownership stake in Oscar Health, Inc.'s Class A Common Stock as of March 31, 2025, filed under SEC Rule 13d-1(b).

Summary

• JPMorgan Chase & Co. has filed a Schedule 13G, disclosing its beneficial ownership in Oscar Health, Inc.'s Class A Common Stock.
• As of March 31, 2025, JPMorgan Chase & Co. beneficially owns an aggregate of 13,810,923 shares of Oscar Health, Inc. Class A Common Stock.
• This ownership represents 6.4% of the Class A Common Stock outstanding.
• The filing indicates that JPMorgan Chase & Co. holds sole voting power over 13,025,334 shares and sole dispositive power over 13,775,322 shares.
• Shared voting power is 0.00 shares, and shared dispositive power is 28,401 shares.
• The filing is made under Rule 13d-1(b), signifying that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Subsidiaries involved in the beneficial ownership include J.P. Morgan Securities LLC, JPMorgan Asset Management (UK) Limited, J.P. MORGAN SE, JPMorgan Chase Bank, National Association, and J.P. Morgan Investment Management Inc.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a reputable financial institution like JPMorgan Chase & Co. is generally viewed positively by the market, signaling confidence in the issuer.

Positives

• The disclosure of a significant 6.4% stake by a major financial institution like JPMorgan Chase & Co. can be interpreted as a vote of confidence in Oscar Health, Inc.'s long-term prospects.
• The passive nature of the investment (Rule 13d-1(b) filing) suggests that JPMorgan Chase & Co. is not seeking to influence control, which can provide stability to the company's governance structure.

Risks

• The document does not detail specific company-related risks for Oscar Health, Inc.
• The filing explicitly states that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, mitigating any immediate risk of a hostile takeover attempt from this specific investor.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Oscar Health, Inc.'s future financial performance or strategic outlook.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing indicates a significant institutional investment by a major financial services firm, JPMorgan Chase & Co., into Oscar Health, Inc., a company operating in the health insurance and healthcare technology sector. Such investments reflect ongoing institutional interest in the evolving healthcare landscape.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be viewed positively, potentially signaling confidence in the company and attracting further investor interest.
• Company Management: The passive nature of the investment suggests no immediate pressure for strategic or operational changes from this specific shareholder.

Key Dates

Keywords

Oscar Health, JPMorgan Chase, Schedule 13G, beneficial ownership, Class A Common Stock, institutional investment, SEC filing, healthcare, financial services